Cost-effectiveness of liver cancer screening

Abstract Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection of HCC for curative treatment is increased by surveillance, but target population, optimal periodicity and cost-effectiveness aspects are st...

Full description

Saved in:
Bibliographic Details
Published inBaillière's best practice & research. Clinical gastroenterology Vol. 27; no. 6; pp. 961 - 972
Main Authors Cucchetti, Alessandro, MD, Cescon, Matteo, MD, Erroi, Virginia, MD, Pinna, Antonio D., MD
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.12.2013
Elsevier Limited
Subjects
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - economics
Carcinoma, Hepatocellular - pathology
Cirrhosis
Clinical trials
Cost-benefit
Cost-Benefit Analysis
Cost-effectiveness
Costs
Early Detection of Cancer - economics
Gastroenterology and Hepatology
Growth models
Health Care Costs
Hepatitis
Hepatocellular carcinoma
Humans
Infections
Liver - pathology
Liver cancer
Liver cirrhosis
Liver diseases
Liver Neoplasms - diagnosis
Liver Neoplasms - economics
Liver Neoplasms - pathology
Medical screening
Mortality
Patients
Prevention & control
Screening
Surveillance
Ultrasonic imaging
United States > US
Liver cancer
Cost-benefit
Cirrhosis
Screening
Surveillance
Hepatocellular carcinoma
Cost-effectiveness
Prevention & control
Online AccessGet full text

Cover

Abstract Abstract Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection of HCC for curative treatment is increased by surveillance, but target population, optimal periodicity and cost-effectiveness aspects are still debated issues. The aim of surveillance is to obtain a reduction in HCC-related mortality and this is usually achieved through an early diagnosis that increases both applicability and cost-effectiveness of curative treatments. The aim of the present review is to analyse economic aspects of HCC surveillance. Articles that assessed cost-effectiveness of surveillance for HCC, published between 1996 and February 2013, were reviewed in order to verify the cost-effectiveness of surveillance, its optimal periodicity, the target population and the role of alternative surveillance strategies. International guidelines are currently based on the results of such cost-effectiveness analyses, highlighting the importance of the release of cost-effectiveness-guided guidelines for HCC management.
AbstractList Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection of HCC for curative treatment is increased by surveillance, but target population, optimal periodicity and cost-effectiveness aspects are still debated issues. The aim of surveillance is to obtain a reduction in HCC-related mortality and this is usually achieved through an early diagnosis that increases both applicability and cost-effectiveness of curative treatments. The aim of the present review is to analyse economic aspects of HCC surveillance. Articles that assessed cost-effectiveness of surveillance for HCC, published between 1996 and February 2013, were reviewed in order to verify the cost-effectiveness of surveillance, its optimal periodicity, the target population and the role of alternative surveillance strategies. International guidelines are currently based on the results of such cost-effectiveness analyses, highlighting the importance of the release of cost-effectiveness-guided guidelines for HCC management.
Abstract Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection of HCC for curative treatment is increased by surveillance, but target population, optimal periodicity and cost-effectiveness aspects are still debated issues. The aim of surveillance is to obtain a reduction in HCC-related mortality and this is usually achieved through an early diagnosis that increases both applicability and cost-effectiveness of curative treatments. The aim of the present review is to analyse economic aspects of HCC surveillance. Articles that assessed cost-effectiveness of surveillance for HCC, published between 1996 and February 2013, were reviewed in order to verify the cost-effectiveness of surveillance, its optimal periodicity, the target population and the role of alternative surveillance strategies. International guidelines are currently based on the results of such cost-effectiveness analyses, highlighting the importance of the release of cost-effectiveness-guided guidelines for HCC management.
Author Pinna, Antonio D., MD
Cucchetti, Alessandro, MD
Cescon, Matteo, MD
Erroi, Virginia, MD
Author_xml – sequence: 1
  fullname: Cucchetti, Alessandro, MD
– sequence: 2
  fullname: Cescon, Matteo, MD
– sequence: 3
  fullname: Erroi, Virginia, MD
– sequence: 4
  fullname: Pinna, Antonio D., MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24182614$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1rGzEQhkVJqJ20P6CXYMilh-xGI-3qg0CgmCQNBHJoC70JWTsyctdaV7ID-ffR4jQBH3qaOTzvID3vCTmKQ0RCvgCtgYK4XNWLzbJmFHhNVU0ZfCBTaDmrQIM4GncGldCgJuQk5xWlJaT1RzJhDSgmoJmSi_mQtxV6j24bnjBizrPBz_qyp5mz0ZWRXUKMIS4_kWNv-4yfX-cp-XV783P-vXp4vLuff3uoXMPFtmpVx1vWdtYzBKUEUtk41TZeC8allt0CWiWlElRBx1SnPCyY8N46oFZbyU_J1_3dTRr-7jBvzTpkh31vIw67bKBpNJOaKV7Q8wN0NexSLK8bKcVl2_CRgj3l0pBzQm82KaxtejZAzajSrExRaUaVhipTVJbM2evl3WKN3Vvin7sCXO0BLCqeAiaTXcBirAup2DTdEP57_vog7foQg7P9H3zG_P4Lk5mh5sfY5Vgl8NKikr_5C-b1l6M
CODEN BPRCB6
CitedBy_id crossref_primary_10_1111_liv_12965
crossref_primary_10_7861_clinmedicine_18_2_s66
crossref_primary_10_1002_hep_28961
crossref_primary_10_34161_johta_2017_5_1_007
crossref_primary_10_1053_j_gastro_2017_06_012
crossref_primary_10_1038_s41598_018_31839_y
crossref_primary_10_1002_hep_29315
crossref_primary_10_1038_s41575_023_00818_8
crossref_primary_10_1097_MCG_0000000000000306
crossref_primary_10_1002_hep_31845
crossref_primary_10_1038_bjc_2014_536
crossref_primary_10_1055_a_1589_7568
crossref_primary_10_1055_a_2189_6353
crossref_primary_10_33590_emjhepatol_10311703
crossref_primary_10_2174_1381612826666200429093648
crossref_primary_10_3390_biomedicines11010166
crossref_primary_10_1007_s40134_019_0317_9
crossref_primary_10_7314_APJCP_2014_15_4_1567
crossref_primary_10_1007_s40273_019_00839_9
crossref_primary_10_1055_a_2026_1240
crossref_primary_10_17116_dokgastro20231204154
crossref_primary_10_1148_rg_2020200104
crossref_primary_10_1111_liv_15032
crossref_primary_10_1053_j_gastro_2018_08_024
crossref_primary_10_12998_wjcc_v7_i16_2269
crossref_primary_10_1111_jgh_13925
crossref_primary_10_3390_cancers13051023
crossref_primary_10_1159_000445407
crossref_primary_10_1055_a_2189_8567
crossref_primary_10_1016_j_dld_2016_08_114
crossref_primary_10_1016_j_jhep_2021_06_041
crossref_primary_10_1097_HEP_0000000000000339
crossref_primary_10_1097_HEP_0000000000000615
crossref_primary_10_1155_2020_9181368
Cites_doi 10.1016/j.jhep.2011.12.001
10.1002/hep.24199
10.1016/j.jhep.2011.10.027
10.1136/gut.48.2.251
10.1053/jlts.2003.50120
10.1016/S0002-9343(96)00197-0
10.1002/hep.24545
10.1016/j.jhep.2011.11.022
10.1111/j.1872-034X.2007.00216.x
10.1258/096914103771773320
10.1016/j.cgh.2012.12.046
10.1111/j.1572-0241.1999.01448.x
10.1002/hep.510310211
10.1007/s00432-004-0552-0
10.1002/hep.1840180109
10.1111/j.1365-2753.2010.01432.x
10.1001/jama.1996.03540160061034
10.1111/j.1872-034X.2011.00936.x
10.1002/hep.26221
10.1016/S1665-2681(19)32093-9
10.1002/1097-0142(19900401)65:7<1607::AID-CNCR2820650726>3.0.CO;2-2
10.1111/j.1440-1746.2009.06203.x
10.1038/sj.bjc.6604301
10.1056/NEJMra1001683
10.1016/S0168-8278(05)80307-1
10.1111/j.1572-0241.2002.05557.x
10.1016/S0168-8278(01)00130-1
10.1111/j.1572-0241.2003.07327.x
10.1038/sj.bjc.6690228
10.1002/hep.1840160122
10.1016/S1542-3565(04)00443-4
10.1002/hep.24581
10.1016/j.cgh.2008.08.005
10.1111/j.1365-2036.2004.01963.x
10.1007/s12072-010-9165-7
10.1002/hep.23615
10.1111/j.1440-1746.2007.05054.x
10.1053/jhep.2003.50093
10.1016/j.jhep.2010.03.010
10.1056/NEJM199306243282501
ContentType Journal Article
Copyright Elsevier Ltd
2013 Elsevier Ltd
Copyright © 2013 Elsevier Ltd. All rights reserved.
Copyright Elsevier Limited Jan 2013
Copyright_xml – notice: Elsevier Ltd
– notice: 2013 Elsevier Ltd
– notice: Copyright © 2013 Elsevier Ltd. All rights reserved.
– notice: Copyright Elsevier Limited Jan 2013
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
7X8
DOI 10.1016/j.bpg.2013.08.021
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-1916
EndPage 972
ExternalDocumentID 3117256021
10_1016_j_bpg_2013_08_021
24182614
S152169181300187X
1_s2_0_S152169181300187X
Genre Journal Article
Review
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
7RV
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BENPR
BKEYQ
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CAG
COF
DU5
EBS
EFJIC
EJD
EMOBN
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M0T
M1P
M2O
M41
MO0
N9A
O-L
O9-
OAUVE
OC.
ON0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SEL
SES
SEW
SSH
SSZ
SV3
T5K
UHS
WOW
Z5R
~G-
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
AAXKI
AFJKZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c436t-58d3525daf2e1886e074c854f9623797db1587786081d28d8f1b26ffac10a9a73
IEDL.DBID AIKHN
ISSN 1521-6918
IngestDate Sat Oct 05 04:25:16 EDT 2024
Fri Sep 13 00:49:03 EDT 2024
Thu Sep 26 15:42:19 EDT 2024
Sat Sep 28 07:52:16 EDT 2024
Fri Feb 23 02:29:29 EST 2024
Tue Jul 23 07:58:03 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Liver cancer
Cost-benefit
Cirrhosis
Screening
Surveillance
Hepatocellular carcinoma
Cost-effectiveness
Prevention & control
Language English
License Copyright © 2013 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c436t-58d3525daf2e1886e074c854f9623797db1587786081d28d8f1b26ffac10a9a73
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMID 24182614
PQID 1448375433
PQPubID 1226366
PageCount 12
ParticipantIDs proquest_miscellaneous_1449279283
proquest_journals_1448375433
crossref_primary_10_1016_j_bpg_2013_08_021
pubmed_primary_24182614
elsevier_sciencedirect_doi_10_1016_j_bpg_2013_08_021
elsevier_clinicalkeyesjournals_1_s2_0_S152169181300187X
PublicationCentury 2000
PublicationDate 2013-12-01
PublicationDateYYYYMMDD 2013-12-01
PublicationDate_xml – month: 12
  year: 2013
  text: 2013-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Kidlington
PublicationTitle Baillière's best practice & research. Clinical gastroenterology
PublicationTitleAlternate Best Pract Res Clin Gastroenterol
PublicationYear 2013
Publisher Elsevier Ltd
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier Limited
References El Serag (bib1) 2011; 365
(bib39) 1996
Zaman, Johnson, Williams (bib11) 1990; 65
Tanaka, Iijima, Nouso, Aoki, Iwai, Takashima (bib37) 2012; 42
Makuuchi, Kokudo, Arii, Futagawa, Kaneko, Kawasaki (bib21) 2008; 38
Chang, Lairson, Chan, Lu, Aoki (bib28) 2011; 17
Yuen, Cheng, Lauder, Lam, Ooi, Lai (bib8) 2000; 31
Zhang, Yang, Tang (bib17) 2004; 130
Cammà, Cabibbo, Petta, Enea, Iavarone, Grieco (bib42) 2013; 57
Lin, Keeffe, Sanders, Owens (bib35) 2004; 19
Arguedas, Chen, Eloubeidi, Fallon (bib29) 2003; 98
Tsukuma, Hiyama, Tanaka, Nakao, Yabuuchi, Kitamura (bib4) 1993; 328
Santi, Trevisani, Gramenzi, Grignaschi, Mirici-Cappa, Del Poggio (bib23) 2010; 53
European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (bib13) 2012; 56
Chalasani, Sr, Said, Hoen, Kopecky, Stockberger (bib10) 1999; 94
Qian, Yuwei, Angus, Schelleman, Johnson, Gow (bib25) 2010; 25
Thompson Coon, Rogers, Hewson, Wright, Anderson, Jackson (bib34) 2008; 98
Patel, Terrault, Yao, Bass, Ladabaum (bib27) 2005; 3
Barbara, Benzi, Gaiani, Fusconi, Zironi, Siringo (bib19) 1992; 16
Davila, Morgan, Richardson, Du, McGlynn, El-Serag (bib12) 2010; 52
Sarasin, Giostra, Hadengue (bib31) 1996; 101
Trinchet, Chaffaut, Bourcier, Degos, Henrion, Fontaine (bib22) 2011; 54
Poustchi, Farrell, Strasser, Lee, McCaughan, George (bib16) 2011; 54
Andersson, Salomon, Goldie, Chung (bib33) 2008; 6
El-Serag, Kanwal (bib41) 2013; 11
Baffy, Brunt, Caldwell (bib7) 2012; 56
Omata, Lesmana, Tateishi, Chen, Lin, Yoshida (bib15) 2010; 4
Will, Le Petit, Berthelot, Tomiak, Verma, Evans (bib38) 1999; 79
Ikeda, Saitoh, Koida, Arase, Tsubota, Chayama (bib3) 1993; 18
Bruix, Sherman (bib14) 2011; 53
Ruelas-Villavicencio, Vargas-Vorácková (bib36) 2004; 3
Chen, Parkin, Chen, Lu, Shen, Zhang (bib18) 2003; 10
Surveillance, Epidemiology, and End Results (SEER) Program (bib2) April 2010
Cucchetti, Trevisani, Cescon, Ercolani, Farinati, Del Poggio (bib26) 2012; 56
Farinati, Floreani, De Maria, Fagiuoli, Naccarato, Chiaramonte (bib6) 1994; 21
Siegel, Weinstein, Russell, Gold (bib40) 1996; 276
Velázquez, Rodríguez, Navascués, Linares, Pérez, Sotorríos (bib5) 2003; 37
Saab, Ly, Nieto, Kanwal, Lu, Raman (bib30) 2003; 9
Bruix, Sherman, Llovet, Beaugrand, Lencioni, Burroughs (bib20) 2001; 35
Bolondi, Sofia, Siringo, Gaiani, Casali, Zironi (bib24) 2001; 48
Trevisani, De Notariis, Rapaccini, Farinati, Benvegnù, Zoli (bib9) 2002; 97
Nouso, Tanaka, Uematsu, Shiraga, Okamoto, Onishi (bib32) 2008; 23
Davila (10.1016/j.bpg.2013.08.021_bib12) 2010; 52
Zaman (10.1016/j.bpg.2013.08.021_bib11) 1990; 65
Poustchi (10.1016/j.bpg.2013.08.021_bib16) 2011; 54
Will (10.1016/j.bpg.2013.08.021_bib38) 1999; 79
Lin (10.1016/j.bpg.2013.08.021_bib35) 2004; 19
Baffy (10.1016/j.bpg.2013.08.021_bib7) 2012; 56
Yuen (10.1016/j.bpg.2013.08.021_bib8) 2000; 31
Ruelas-Villavicencio (10.1016/j.bpg.2013.08.021_bib36) 2004; 3
Chalasani (10.1016/j.bpg.2013.08.021_bib10) 1999; 94
Zhang (10.1016/j.bpg.2013.08.021_bib17) 2004; 130
Santi (10.1016/j.bpg.2013.08.021_bib23) 2010; 53
Nouso (10.1016/j.bpg.2013.08.021_bib32) 2008; 23
Cucchetti (10.1016/j.bpg.2013.08.021_bib26) 2012; 56
Arguedas (10.1016/j.bpg.2013.08.021_bib29) 2003; 98
El-Serag (10.1016/j.bpg.2013.08.021_bib41) 2013; 11
Farinati (10.1016/j.bpg.2013.08.021_bib6) 1994; 21
Barbara (10.1016/j.bpg.2013.08.021_bib19) 1992; 16
Tanaka (10.1016/j.bpg.2013.08.021_bib37) 2012; 42
Surveillance, Epidemiology, and End Results (SEER) Program (10.1016/j.bpg.2013.08.021_bib2) 2010
Siegel (10.1016/j.bpg.2013.08.021_bib40) 1996; 276
Trinchet (10.1016/j.bpg.2013.08.021_bib22) 2011; 54
Patel (10.1016/j.bpg.2013.08.021_bib27) 2005; 3
Omata (10.1016/j.bpg.2013.08.021_bib15) 2010; 4
Tsukuma (10.1016/j.bpg.2013.08.021_bib4) 1993; 328
Velázquez (10.1016/j.bpg.2013.08.021_bib5) 2003; 37
Bruix (10.1016/j.bpg.2013.08.021_bib14) 2011; 53
European Association for the Study of the Liver (10.1016/j.bpg.2013.08.021_bib13) 2012; 56
Andersson (10.1016/j.bpg.2013.08.021_bib33) 2008; 6
Cammà (10.1016/j.bpg.2013.08.021_bib42) 2013; 57
Sarasin (10.1016/j.bpg.2013.08.021_bib31) 1996; 101
Ikeda (10.1016/j.bpg.2013.08.021_bib3) 1993; 18
Bolondi (10.1016/j.bpg.2013.08.021_bib24) 2001; 48
Qian (10.1016/j.bpg.2013.08.021_bib25) 2010; 25
Trevisani (10.1016/j.bpg.2013.08.021_bib9) 2002; 97
El Serag (10.1016/j.bpg.2013.08.021_bib1) 2011; 365
(10.1016/j.bpg.2013.08.021_bib39) 1996
Makuuchi (10.1016/j.bpg.2013.08.021_bib21) 2008; 38
Saab (10.1016/j.bpg.2013.08.021_bib30) 2003; 9
Thompson Coon (10.1016/j.bpg.2013.08.021_bib34) 2008; 98
Bruix (10.1016/j.bpg.2013.08.021_bib20) 2001; 35
Chang (10.1016/j.bpg.2013.08.021_bib28) 2011; 17
Chen (10.1016/j.bpg.2013.08.021_bib18) 2003; 10
References_xml – volume: 17
  start-page: 261
  year: 2011
  end-page: 267
  ident: bib28
  article-title: Cost-effectiveness of screening for hepatocellular carcinoma among subjects at different levels of risk
  publication-title: J Eval Clin Pract
  contributor:
    fullname: Aoki
– volume: 16
  start-page: 132
  year: 1992
  end-page: 137
  ident: bib19
  article-title: Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival
  publication-title: Hepatology
  contributor:
    fullname: Siringo
– volume: 56
  start-page: 1384
  year: 2012
  end-page: 1391
  ident: bib7
  article-title: Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace
  publication-title: J Hepatol
  contributor:
    fullname: Caldwell
– volume: 42
  start-page: 376
  year: 2012
  end-page: 384
  ident: bib37
  article-title: Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography
  publication-title: Hepatol Res
  contributor:
    fullname: Takashima
– volume: 328
  start-page: 1797
  year: 1993
  end-page: 1801
  ident: bib4
  article-title: Risk factors for hepatocellular carcinoma among patients with chronic liver disease
  publication-title: N Engl J Med
  contributor:
    fullname: Kitamura
– volume: 54
  start-page: 1998
  year: 2011
  end-page: 2004
  ident: bib16
  article-title: Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?
  publication-title: Hepatology
  contributor:
    fullname: George
– volume: 38
  start-page: 37
  year: 2008
  end-page: 51
  ident: bib21
  article-title: Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
  publication-title: Hepatol Res
  contributor:
    fullname: Kawasaki
– volume: 3
  start-page: 152
  year: 2004
  end-page: 159
  ident: bib36
  article-title: In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
  publication-title: Ann Hepatol
  contributor:
    fullname: Vargas-Vorácková
– volume: 23
  start-page: 437
  year: 2008
  end-page: 444
  ident: bib32
  article-title: Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances
  publication-title: J Gastroenterol Hepatol
  contributor:
    fullname: Onishi
– volume: 276
  start-page: 1339
  year: 1996
  end-page: 1341
  ident: bib40
  article-title: ecommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine
  publication-title: J Am Med Assoc
  contributor:
    fullname: Gold
– volume: 11
  start-page: 441
  year: 2013
  end-page: 443
  ident: bib41
  article-title: α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it
  publication-title: Clin Gastroenterol Hepatol
  contributor:
    fullname: Kanwal
– volume: 21
  start-page: 315
  year: 1994
  end-page: 316
  ident: bib6
  article-title: Hepatocellular carcinoma in primary biliary cirrhosis
  publication-title: J Hepatol
  contributor:
    fullname: Chiaramonte
– volume: 65
  start-page: 1607
  year: 1990
  end-page: 1610
  ident: bib11
  article-title: Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas
  publication-title: Cancer
  contributor:
    fullname: Williams
– volume: 9
  start-page: 672
  year: 2003
  end-page: 681
  ident: bib30
  article-title: Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model
  publication-title: Liver Transpl
  contributor:
    fullname: Raman
– year: 1996
  ident: bib39
  publication-title: Cost-effectiveness in health and medicine
– volume: 98
  start-page: 1166
  year: 2008
  end-page: 1175
  ident: bib34
  article-title: Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis
  publication-title: Br J Cancer
  contributor:
    fullname: Jackson
– year: April 2010
  ident: bib2
  article-title: SEER*Stat database: incidence — SEER 9 Regs research data, Nov 2009 Sub (1973–2007)
  contributor:
    fullname: Surveillance, Epidemiology, and End Results (SEER) Program
– volume: 57
  start-page: 1046
  year: 2013
  end-page: 1054
  ident: bib42
  article-title: Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
  publication-title: Hepatology
  contributor:
    fullname: Grieco
– volume: 52
  start-page: 132
  year: 2010
  end-page: 141
  ident: bib12
  article-title: Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States
  publication-title: Hepatology
  contributor:
    fullname: El-Serag
– volume: 53
  start-page: 291
  year: 2010
  end-page: 297
  ident: bib23
  article-title: Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
  publication-title: J Hepatol
  contributor:
    fullname: Del Poggio
– volume: 4
  start-page: 439
  year: 2010
  end-page: 474
  ident: bib15
  article-title: Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
  publication-title: Hepatol Int
  contributor:
    fullname: Yoshida
– volume: 31
  start-page: 330
  year: 2000
  end-page: 335
  ident: bib8
  article-title: Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
  publication-title: Hepatology
  contributor:
    fullname: Lai
– volume: 365
  start-page: 1118
  year: 2011
  end-page: 1127
  ident: bib1
  article-title: Hepatocellular carcinoma
  publication-title: N Engl J Med
  contributor:
    fullname: El Serag
– volume: 37
  start-page: 520
  year: 2003
  end-page: 527
  ident: bib5
  article-title: Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
  publication-title: Hepatology
  contributor:
    fullname: Sotorríos
– volume: 130
  start-page: 417
  year: 2004
  end-page: 422
  ident: bib17
  article-title: Randomized controlled trial of screening for hepatocellular carcinoma
  publication-title: J Cancer Res Clin Oncol
  contributor:
    fullname: Tang
– volume: 56
  start-page: 908
  year: 2012
  end-page: 943
  ident: bib13
  article-title: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
  publication-title: J Hepatol
  contributor:
    fullname: European Organisation for Research and Treatment of Cancer
– volume: 10
  start-page: 204
  year: 2003
  end-page: 209
  ident: bib18
  article-title: Screening for liver cancer: results of a randomised controlled trial in Qidong, China
  publication-title: J Med Screen
  contributor:
    fullname: Zhang
– volume: 101
  start-page: 422
  year: 1996
  end-page: 434
  ident: bib31
  article-title: Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
  publication-title: Am J Med
  contributor:
    fullname: Hadengue
– volume: 53
  start-page: 1020
  year: 2011
  end-page: 1022
  ident: bib14
  article-title: Management of hepatocellular carcinoma: an update. Alexandria (VA): American Association for the Study of Liver Diseases
  publication-title: Hepatology
  contributor:
    fullname: Sherman
– volume: 3
  start-page: 75
  year: 2005
  end-page: 84
  ident: bib27
  article-title: Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis
  publication-title: Clin Gastroenterol Hepatol
  contributor:
    fullname: Ladabaum
– volume: 54
  start-page: 1987
  year: 2011
  end-page: 1997
  ident: bib22
  article-title: Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities
  publication-title: Hepatology
  contributor:
    fullname: Fontaine
– volume: 25
  start-page: 951
  year: 2010
  end-page: 956
  ident: bib25
  article-title: Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital
  publication-title: J Gastroenterol Hepatol
  contributor:
    fullname: Gow
– volume: 56
  start-page: 1089
  year: 2012
  end-page: 1096
  ident: bib26
  article-title: Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian liver cancer population
  publication-title: J Hepatol
  contributor:
    fullname: Del Poggio
– volume: 79
  start-page: 1428
  year: 1999
  end-page: 1436
  ident: bib38
  article-title: Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs
  publication-title: Br J Cancer
  contributor:
    fullname: Evans
– volume: 18
  start-page: 47
  year: 1993
  end-page: 53
  ident: bib3
  article-title: A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis
  publication-title: Hepatology
  contributor:
    fullname: Chayama
– volume: 35
  start-page: 421
  year: 2001
  end-page: 430
  ident: bib20
  article-title: European Association for the Study of the Liver. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference
  publication-title: J Hepatol
  contributor:
    fullname: Burroughs
– volume: 48
  start-page: 251
  year: 2001
  end-page: 259
  ident: bib24
  article-title: Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
  publication-title: Gut
  contributor:
    fullname: Zironi
– volume: 19
  start-page: 1159
  year: 2004
  end-page: 1172
  ident: bib35
  article-title: Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
  publication-title: Aliment Pharmacol Ther
  contributor:
    fullname: Owens
– volume: 94
  start-page: 2988
  year: 1999
  end-page: 2993
  ident: bib10
  article-title: Screening for hepatocellular carcinoma in patients with advanced cirrhosis
  publication-title: Am J Gastroenterol
  contributor:
    fullname: Stockberger
– volume: 97
  start-page: 734
  year: 2002
  end-page: 744
  ident: bib9
  article-title: Semi-annual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)
  publication-title: Am J Gastroenterol
  contributor:
    fullname: Zoli
– volume: 98
  start-page: 679
  year: 2003
  end-page: 690
  ident: bib29
  article-title: Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis
  publication-title: Am J Gastroenterol
  contributor:
    fullname: Fallon
– volume: 6
  start-page: 1418
  year: 2008
  end-page: 1424
  ident: bib33
  article-title: Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis
  publication-title: Clin Gastroenterol Hepatol
  contributor:
    fullname: Chung
– year: 2010
  ident: 10.1016/j.bpg.2013.08.021_bib2
  contributor:
    fullname: Surveillance, Epidemiology, and End Results (SEER) Program
– volume: 56
  start-page: 908
  year: 2012
  ident: 10.1016/j.bpg.2013.08.021_bib13
  article-title: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.12.001
  contributor:
    fullname: European Association for the Study of the Liver
– volume: 53
  start-page: 1020
  year: 2011
  ident: 10.1016/j.bpg.2013.08.021_bib14
  article-title: Management of hepatocellular carcinoma: an update. Alexandria (VA): American Association for the Study of Liver Diseases
  publication-title: Hepatology
  doi: 10.1002/hep.24199
  contributor:
    fullname: Bruix
– volume: 56
  start-page: 1384
  year: 2012
  ident: 10.1016/j.bpg.2013.08.021_bib7
  article-title: Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.10.027
  contributor:
    fullname: Baffy
– volume: 48
  start-page: 251
  year: 2001
  ident: 10.1016/j.bpg.2013.08.021_bib24
  article-title: Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
  publication-title: Gut
  doi: 10.1136/gut.48.2.251
  contributor:
    fullname: Bolondi
– volume: 9
  start-page: 672
  year: 2003
  ident: 10.1016/j.bpg.2013.08.021_bib30
  article-title: Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model
  publication-title: Liver Transpl
  doi: 10.1053/jlts.2003.50120
  contributor:
    fullname: Saab
– volume: 101
  start-page: 422
  year: 1996
  ident: 10.1016/j.bpg.2013.08.021_bib31
  article-title: Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(96)00197-0
  contributor:
    fullname: Sarasin
– volume: 54
  start-page: 1987
  year: 2011
  ident: 10.1016/j.bpg.2013.08.021_bib22
  article-title: Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities
  publication-title: Hepatology
  doi: 10.1002/hep.24545
  contributor:
    fullname: Trinchet
– volume: 56
  start-page: 1089
  year: 2012
  ident: 10.1016/j.bpg.2013.08.021_bib26
  article-title: Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian liver cancer population
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.11.022
  contributor:
    fullname: Cucchetti
– volume: 38
  start-page: 37
  year: 2008
  ident: 10.1016/j.bpg.2013.08.021_bib21
  article-title: Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2007.00216.x
  contributor:
    fullname: Makuuchi
– volume: 10
  start-page: 204
  year: 2003
  ident: 10.1016/j.bpg.2013.08.021_bib18
  article-title: Screening for liver cancer: results of a randomised controlled trial in Qidong, China
  publication-title: J Med Screen
  doi: 10.1258/096914103771773320
  contributor:
    fullname: Chen
– volume: 11
  start-page: 441
  year: 2013
  ident: 10.1016/j.bpg.2013.08.021_bib41
  article-title: α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2012.12.046
  contributor:
    fullname: El-Serag
– volume: 94
  start-page: 2988
  year: 1999
  ident: 10.1016/j.bpg.2013.08.021_bib10
  article-title: Screening for hepatocellular carcinoma in patients with advanced cirrhosis
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01448.x
  contributor:
    fullname: Chalasani
– volume: 31
  start-page: 330
  year: 2000
  ident: 10.1016/j.bpg.2013.08.021_bib8
  article-title: Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
  publication-title: Hepatology
  doi: 10.1002/hep.510310211
  contributor:
    fullname: Yuen
– year: 1996
  ident: 10.1016/j.bpg.2013.08.021_bib39
– volume: 130
  start-page: 417
  year: 2004
  ident: 10.1016/j.bpg.2013.08.021_bib17
  article-title: Randomized controlled trial of screening for hepatocellular carcinoma
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-004-0552-0
  contributor:
    fullname: Zhang
– volume: 18
  start-page: 47
  year: 1993
  ident: 10.1016/j.bpg.2013.08.021_bib3
  article-title: A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis
  publication-title: Hepatology
  doi: 10.1002/hep.1840180109
  contributor:
    fullname: Ikeda
– volume: 17
  start-page: 261
  year: 2011
  ident: 10.1016/j.bpg.2013.08.021_bib28
  article-title: Cost-effectiveness of screening for hepatocellular carcinoma among subjects at different levels of risk
  publication-title: J Eval Clin Pract
  doi: 10.1111/j.1365-2753.2010.01432.x
  contributor:
    fullname: Chang
– volume: 276
  start-page: 1339
  year: 1996
  ident: 10.1016/j.bpg.2013.08.021_bib40
  article-title: ecommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.1996.03540160061034
  contributor:
    fullname: Siegel
– volume: 42
  start-page: 376
  year: 2012
  ident: 10.1016/j.bpg.2013.08.021_bib37
  article-title: Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography
  publication-title: Hepatol Res
  doi: 10.1111/j.1872-034X.2011.00936.x
  contributor:
    fullname: Tanaka
– volume: 57
  start-page: 1046
  year: 2013
  ident: 10.1016/j.bpg.2013.08.021_bib42
  article-title: Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.26221
  contributor:
    fullname: Cammà
– volume: 3
  start-page: 152
  year: 2004
  ident: 10.1016/j.bpg.2013.08.021_bib36
  article-title: In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
  publication-title: Ann Hepatol
  doi: 10.1016/S1665-2681(19)32093-9
  contributor:
    fullname: Ruelas-Villavicencio
– volume: 65
  start-page: 1607
  year: 1990
  ident: 10.1016/j.bpg.2013.08.021_bib11
  article-title: Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas
  publication-title: Cancer
  doi: 10.1002/1097-0142(19900401)65:7<1607::AID-CNCR2820650726>3.0.CO;2-2
  contributor:
    fullname: Zaman
– volume: 25
  start-page: 951
  year: 2010
  ident: 10.1016/j.bpg.2013.08.021_bib25
  article-title: Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2009.06203.x
  contributor:
    fullname: Qian
– volume: 98
  start-page: 1166
  year: 2008
  ident: 10.1016/j.bpg.2013.08.021_bib34
  article-title: Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6604301
  contributor:
    fullname: Thompson Coon
– volume: 365
  start-page: 1118
  year: 2011
  ident: 10.1016/j.bpg.2013.08.021_bib1
  article-title: Hepatocellular carcinoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1001683
  contributor:
    fullname: El Serag
– volume: 21
  start-page: 315
  year: 1994
  ident: 10.1016/j.bpg.2013.08.021_bib6
  article-title: Hepatocellular carcinoma in primary biliary cirrhosis
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(05)80307-1
  contributor:
    fullname: Farinati
– volume: 97
  start-page: 734
  year: 2002
  ident: 10.1016/j.bpg.2013.08.021_bib9
  article-title: Semi-annual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2002.05557.x
  contributor:
    fullname: Trevisani
– volume: 35
  start-page: 421
  year: 2001
  ident: 10.1016/j.bpg.2013.08.021_bib20
  article-title: European Association for the Study of the Liver. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(01)00130-1
  contributor:
    fullname: Bruix
– volume: 98
  start-page: 679
  year: 2003
  ident: 10.1016/j.bpg.2013.08.021_bib29
  article-title: Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2003.07327.x
  contributor:
    fullname: Arguedas
– volume: 79
  start-page: 1428
  year: 1999
  ident: 10.1016/j.bpg.2013.08.021_bib38
  article-title: Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6690228
  contributor:
    fullname: Will
– volume: 16
  start-page: 132
  year: 1992
  ident: 10.1016/j.bpg.2013.08.021_bib19
  article-title: Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival
  publication-title: Hepatology
  doi: 10.1002/hep.1840160122
  contributor:
    fullname: Barbara
– volume: 3
  start-page: 75
  year: 2005
  ident: 10.1016/j.bpg.2013.08.021_bib27
  article-title: Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/S1542-3565(04)00443-4
  contributor:
    fullname: Patel
– volume: 54
  start-page: 1998
  year: 2011
  ident: 10.1016/j.bpg.2013.08.021_bib16
  article-title: Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?
  publication-title: Hepatology
  doi: 10.1002/hep.24581
  contributor:
    fullname: Poustchi
– volume: 6
  start-page: 1418
  year: 2008
  ident: 10.1016/j.bpg.2013.08.021_bib33
  article-title: Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2008.08.005
  contributor:
    fullname: Andersson
– volume: 19
  start-page: 1159
  year: 2004
  ident: 10.1016/j.bpg.2013.08.021_bib35
  article-title: Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2004.01963.x
  contributor:
    fullname: Lin
– volume: 4
  start-page: 439
  year: 2010
  ident: 10.1016/j.bpg.2013.08.021_bib15
  article-title: Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
  publication-title: Hepatol Int
  doi: 10.1007/s12072-010-9165-7
  contributor:
    fullname: Omata
– volume: 52
  start-page: 132
  year: 2010
  ident: 10.1016/j.bpg.2013.08.021_bib12
  article-title: Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States
  publication-title: Hepatology
  doi: 10.1002/hep.23615
  contributor:
    fullname: Davila
– volume: 23
  start-page: 437
  year: 2008
  ident: 10.1016/j.bpg.2013.08.021_bib32
  article-title: Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2007.05054.x
  contributor:
    fullname: Nouso
– volume: 37
  start-page: 520
  year: 2003
  ident: 10.1016/j.bpg.2013.08.021_bib5
  article-title: Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50093
  contributor:
    fullname: Velázquez
– volume: 53
  start-page: 291
  year: 2010
  ident: 10.1016/j.bpg.2013.08.021_bib23
  article-title: Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.03.010
  contributor:
    fullname: Santi
– volume: 328
  start-page: 1797
  year: 1993
  ident: 10.1016/j.bpg.2013.08.021_bib4
  article-title: Risk factors for hepatocellular carcinoma among patients with chronic liver disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199306243282501
  contributor:
    fullname: Tsukuma
SSID ssj0001699
Score 2.2511628
SecondaryResourceType review_article
Snippet Abstract Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection...
Screening for primary liver cancer means surveillance for hepatocellular carcinoma (HCC), which is one of the most common cancers worldwide. Detection of HCC...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 961
SubjectTerms Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - economics
Carcinoma, Hepatocellular - pathology
Cirrhosis
Clinical trials
Cost-benefit
Cost-Benefit Analysis
Cost-effectiveness
Costs
Early Detection of Cancer - economics
Gastroenterology and Hepatology
Growth models
Health Care Costs
Hepatitis
Hepatocellular carcinoma
Humans
Infections
Liver - pathology
Liver cancer
Liver cirrhosis
Liver diseases
Liver Neoplasms - diagnosis
Liver Neoplasms - economics
Liver Neoplasms - pathology
Medical screening
Mortality
Patients
Prevention & control
Screening
Surveillance
Ultrasonic imaging
Title Cost-effectiveness of liver cancer screening
URI https://www.clinicalkey.es/playcontent/1-s2.0-S152169181300187X
https://dx.doi.org/10.1016/j.bpg.2013.08.021
https://www.ncbi.nlm.nih.gov/pubmed/24182614
https://www.proquest.com/docview/1448375433/abstract/
https://search.proquest.com/docview/1449279283
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFH_oBuJF_HY6pYInsa75atOjDGU69OAH7hbSNRVFtuHm1b_d99p0IqIHLy1tE5K-l_x-L8nLC8CRKgOB0axNHotQJjKmPocXp3JRqDRSOU3oX9_EvQd5NVCDBejWe2HIrdJjf4XpJVr7Nx0vzc7k-blzR8wTp8hQojxZbrAITaQjKRvQPLvs927mgIyp0jJsKmchZagXN0s3r2zyRA5eogzkydlv9PSb-VnS0MUqrHj7MTirqrgGC260DkvXfoV8A0664-ksrLw0PJAF4yJ4JfeLYEgqfgsQKXD0ipy1CQ8X5_fdXuhPRAiHUsSzUOmcwpfmtuCOaR07NACGWskiRSsmSZM8Y0pTRDgk-pzrXBcs43FR2CGLbGoTsQWN0XjkdiBASwtxkEdCaSuziFnOkC4l9nDLCpfYFhzXgjCTKvCFqT3CXgxKzZDUDJ1hyVkLklpUpt7RiRjkpr5DTA0zU24i80NpLZDznN_0bhDS_yqwXSvEfJUhKTy-kkK04HD-GbsLrYHYkRu_l2lSipmoMc12pcj572HrwcEWk7v_q9MeLNNT5evShsbs7d3to8Uyyw5g8fSDHfh2Sff-7WP_EziO5hA
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgSMAF8WY8i8QJUa15tekRTUwbsF0AabcoXVMEQtvExv_HbtMhhODApYcmUVK7_uwkzheAC1USgdGqTR6LUCYyJpvDh1O5KFQaqZwW9PuDuPskb4dquATt-iwMpVV67K8wvURr_6blpdmavry0HsjzxCl6KFHeLDdchhWpEiYbsHLdu-sOFoCMtdKSNpWzkBrUm5tlmlc2faYEL1ESeXL2m3v6Lfws3VBnEzZ8_BhcV0PcgiU33obVvt8h34Gr9mQ2D6ssDQ9kwaQI3ij9IhiRit8DRAqcvaLP2oWnzs1juxv6GxHCkRTxPFQ6J_rS3BbcMa1jhwHASCtZpBjFJGmSZ0xpYoRDR59zneuCZTwuCjtikU1tIvagMZ6M3QEEGGkhDvJIKG1lFjHLGbpLiRZuWeES24TLWhBmWhFfmDoj7NWg1AxJzdAdlpw1IalFZeoTnYhBbuYNYmaYmXETmR9Ka4JctPymd4OQ_leHx7VCzFcfkujxlRSiCeeLYjQX2gOxYzf5KOukxJmosc5-pcjF52Ewg5MtJg__N6YzWOs-9u_NfW9wdwTrVFLlvRxDY_7-4U4weplnp_7v_ASTQeZf
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cost-effectiveness+of+liver+cancer+screening&rft.jtitle=Bailli%C3%A8re%27s+best+practice+%26+research.+Clinical+gastroenterology&rft.au=Cucchetti%2C+Alessandro&rft.au=Cescon%2C+Matteo&rft.au=Erroi%2C+Virginia&rft.au=Pinna%2C+Antonio+D&rft.date=2013-12-01&rft.eissn=1532-1916&rft.volume=27&rft.issue=6&rft.spage=961&rft.epage=972&rft_id=info:doi/10.1016%2Fj.bpg.2013.08.021&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15216918%2FS1521691813X00095%2Fcov150h.gif